04/20/2026 07:00
ILOS Upsizes Credit Facility to €450 Million With EIG and La Caisse

ILOS Projects (“ILOS”), a Pan-European Independent Power Producer (IPP) supported by BNP Paribas Asset Management Alts (BNPP AM Alts), today announced the successful upsizing of its structured credit facility with EIG, a leading institutional investor in the global energy and infrastructure sectors, and La Caisse, a global investment group, for a total of €450 million. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260420576932/en/I...

04/20/2026 08:00
Omdia: AMOLED Smartphone Display Shipments Expected to Decline Sharply in 2026

AMOLED smartphone display shipments are expected to decline sharply in 2026 amid rising memory prices and increasing market uncertainty, according to Omdia’s latest OLED Display Market Tracker. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260417708632/en/AMOLED smartphone display shipment A surge in memory prices since the second half of 2025 has significantly increased component costs for smartphones putting pressure on pricing f...

04/20/2026 08:00
Europe’s Technology Services Market Accelerates in Q1 on Higher Demand for AI: ISG Index™

Demand for technology services in Europe continued to accelerate in the first quarter, driven by strong demand for the cloud-based infrastructure services needed to power AI, the latest state-of-the-industry report from Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, shows. The EMEA ISG Index™, which measures commercial outsourcing contracts with annual contract value (ACV) of US $5 million or more, shows ACV for the combined market (bot...

04/20/2026 08:00
IQOS and Devialet Introduce “Soundsorial Design” Collaboration

Philip Morris International (NYSE: PM) today announced a collaboration between IQOS – the number 1 tobacco heating system1, and Devialet – the French acoustic engineering company, launching “Soundsorial Design” at Milan Design Week 2026. The immersive exhibition is an ethereal landscape of water and light, where sound, movement, and voice become visible across an ever‑changing immersive canvas. A space to push experiential boundaries, where visitors are invited to explore their own frequency ...

04/20/2026 09:00
PPG invests in testing line for radiation-curable coatings at Marly, France

PPG (NYSE: PPG) today announced the installation of an advanced testing line for radiation-curable coatings at its R&D Center of Excellence in Marly, France. The line can test multiple curing technologies, including infrared (IR), ultraviolet (LED, excimer and arc lamps), and electron beam (EB). This investment allows the company to accurately replicate customer production conditions, helping accelerate development cycles and reduce the number of customer trials. Unlike conventional therm...

04/20/2026 10:30
Compass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 2026

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that CEO Kabir Nath will participate in a panel entitled “Clinical Risk, Regulatory Reality and the Path to Scale” at the Needham Virtual Psychedelics Forum on April 27, 2026, at 11am-12pm ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of t...

04/20/2026 10:32
Ushio Industry & Entertainment Appoints Takuya Matsumoto as President & CEO and Outlines Strategic Direction for the Next Phase

Ushio Industry & Entertainment (Ushio INE GmbH) announces the appointment of Takuya Matsumoto as President and Chief Executive Officer, marking a key milestone in the evolution of the business and its integration within the Ushio Group. With more than 20 years of experience across sales, new business development, and global operations, Takuya Matsumoto brings deep industry expertise and a strong leadership track record within Ushio. Most recently, he served as General Manager of the Globa...

04/20/2026 12:00
Saildrone Unveils Spectre, a New Class of High-Speed Unmanned Surface Vessel for Naval Operations

Saildrone, the world leader and most experienced operator of unmanned surface vehicles (USVs), today released the design of the Saildrone Spectre, the culmination of two years of intense design work, leveraging over 10 years of operational USV experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260420620393/en/Two Saildrone Spectre variants are built around different mission needs: Spectre Silent Endurance (right) uses wing a...

04/20/2026 12:17
Data4Industry-X Empowers Industrial Organizations in Meeting Digital Product Passport Requirements

Hannover Messe - Data4Industry-X, the trusted industry data space solution, builds its momentum by accelerating Digital Product Passport (DPP) compliance with trusted, secure and traceable data exchange at scale, as demonstrated at Hannover Messe April 20-24, 2026 . As the Digital Product Passport becomes a regulatory reality for manufacturing organizations, the ability to exchange data in a trusted, secure and traceable environment across the entire supply chain, in compliance with data regula...

04/20/2026 12:30
Following Oral Presentation of Phase I Data at AACR 2026, Debiopharm Announces FDA Fast Track Designation for Lunresertib in Combination With Zedoresertib for Genomic-Defined Platinum-Resistant Ovarian Cancer

Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard of care to cure cancer and infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the combination of its PKMYT1 inhibitor, lunresertib (Debio2513), and its WEE1 inhibitor, zedoresertib (Debio 0123). The designation is for the treatment of adult patients with CCNE1 amplified, or a deleterious mutat...